Xiromed LLC Launches Gemmily™, First-to-Market Generic to Taytulla®
FLORHAM PARK, N.J.–(BUSINESS WIRE)–Xiromed LLC, the New Jersey-based generic division of Insud Pharmaceuticals, today announced the FDA approval of Gemmily™…
Pharmaceuticals, Biotechnology and Life Sciences
FLORHAM PARK, N.J.–(BUSINESS WIRE)–Xiromed LLC, the New Jersey-based generic division of Insud Pharmaceuticals, today announced the FDA approval of Gemmily™…
EDISON, N.J.–(BUSINESS WIRE)–Seven and Eight Biopharmaceuticals Inc., a clinical stage biotechnology company focused on developing proprietary novel immuno-oncology therapies to…
STRASBOURG, France & LUND, Sweden–(BUSINESS WIRE)–#Transgene–Regulatory News: Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based…
Combination of TG4001 and avelumab demonstrated a clinically relevant anti-tumor activity with an overall response rate (ORR) of 23.5%…
ABEC’s fermentation systems to support growing demand for recombinant proteins for biotechnology research BETHLEHEM, Pa.–(BUSINESS WIRE)–#Fermentation—ABEC, a global provider of…
New partnerships in oncology R&D, software advances, and the appointment of a new Board member help drive therapeutic breakthroughs SAN…
DUBLIN–(BUSINESS WIRE)–The “Meningococcal Vaccines – Global Drug Forecast and Market Analysis to 2029” clinical trials has been added to ResearchAndMarkets.com’s…
The Nine Hematology Abstracts Will Present New Data at This Year’s ASH Virtual Annual Meeting CAMBRIDGE, Mass. & OSAKA, Japan–(BUSINESS…
DUBLIN–(BUSINESS WIRE)–The “Gene Editing Technology and its Application in Agriculture” report has been added to ResearchAndMarkets.com’s offering. Gene editing is…
DUBLIN–(BUSINESS WIRE)–The “Male Infertility – Pipeline Review, H2 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. The male infertility…